The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-4-(2,6-Dimethylpyridin-4-yl)-N-(1-(3-methoxyphenyl)-ethyl)benzamide ID: ALA4540054
PubChem CID: 68511029
Max Phase: Preclinical
Molecular Formula: C23H24N2O2
Molecular Weight: 360.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc([C@@H](C)NC(=O)c2ccc(-c3cc(C)nc(C)c3)cc2)c1
Standard InChI: InChI=1S/C23H24N2O2/c1-15-12-21(13-16(2)24-15)18-8-10-19(11-9-18)23(26)25-17(3)20-6-5-7-22(14-20)27-4/h5-14,17H,1-4H3,(H,25,26)/t17-/m1/s1
Standard InChI Key: WBQCULFFYOARKU-QGZVFWFLSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
24.7661 -26.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7649 -27.0604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4730 -27.4694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1826 -27.0599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1798 -26.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4712 -25.8320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8829 -25.8273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5925 -26.2349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2982 -25.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2955 -25.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5813 -24.6006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8786 -25.0135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0011 -24.5941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7109 -24.9991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9970 -23.7769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.4165 -24.5869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1263 -24.9919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1290 -25.8086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8379 -26.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5445 -25.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5377 -24.9799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8282 -24.5787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2418 -24.5652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9531 -24.9677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4124 -23.7697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0583 -25.8325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4728 -28.2866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
23 24 1 0
16 25 1 6
1 26 1 0
3 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.46Molecular Weight (Monoisotopic): 360.1838AlogP: 4.87#Rotatable Bonds: 5Polar Surface Area: 51.22Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.38CX LogP: 3.72CX LogD: 3.68Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -1.04
References 1. Hobson AD, Judge RA, Aguirre AL, Brown BS, Cui Y, Ding P, Dominguez E, DiGiammarino E, Egan DA, Freiberg GM, Gopalakrishnan SM, Harris CM, Honore MP, Kage KL, Kapecki NJ, Ling C, Ma J, Mack H, Mamo M, Maurus S, McRae B, Moore NS, Mueller BK, Mueller R, Namovic MT, Patel K, Pratt SD, Putman CB, Queeney KL, Sarris KK, Schaffter LM, Stoll V, Vasudevan A, Wang L, Wang L, Wirthl W, Yach K.. (2018) Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design., 61 (24): [PMID:30384606 ] [10.1021/acs.jmedchem.8b01098 ]